Clinical Trial Update: A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the safety and effectiveness of GSK5764227 alone or with other treatments in adults with advanced, unresectable gastrointe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neoplasms

Drugs mentioned

• GSK5764227

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastrointestinal Neoplasms | Phase 1, Phase 2 | Status: RECRUITING